Health-related quality of life (HRQOL) in chronic graft versus host disease

Chronic Graft Versus Host Disease: Interdisciplinary Management

Volumn , Issue , 2009, Pages 335-348

  Mitchell, Sandra A ^a   Reeve, Bryce B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78149407932     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511576751.031     Document Type: Chapter

References (107)

1. Chiodi S, Spinelli S, Ravera G, et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol. 2000;110(3):614–619.
2. Sutherland HJ, Fyles GM, Adams G, et al. Quality of life following bone marrow transplantation: A comparison of patient reports with population norms. Bone Marrow Transplantation. 1997;19(11):1129–1136.
3. Baker KS, Gurney JG, Ness KK, et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: Results from the Bone Marrow Transplant Survivor Study. Blood. Sep 15 2004;104(6):1898–1906.
4. Syrjala KL, Langer S, Abrams J, Storer B, Martin P. Physical and mental recovery after hematopoietic stem cell transplantation. Discovery Medicine. Oct 2004;4(23):263–269.
5. Syrjala KL, Langer SL, Abrams JR, et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. J Am Med Assoc. 2004;291(19):2335–2343.
6. Acquadro C, Berzon R, Dubois D, et al. Incorporating the patient’s perspective into drug development and communication: An ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. Sep-Oct 2003;6(5):522–531.
7. Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res. 2000;9(8):887.
8. Minasian LM, O’Mara A. Introduction. J Natl Cancer Inst Monogr. 2007(37):1–2.
9. Ganz PA, Goodwin PJ. Health-related quality of life measurement in symptom management trials. J Natl Cancer Inst Monogr. 2007(37):47–52.
10. Pavletic SZ, Martin P, Lee SJ, et al. Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report. Biol Blood Marrow Transplant. Mar 2006;12(3):252–266.
11. IOM. From cancer patient to survivor: Lost in transition. Washington DC: National Academies Press; 2006.
12. Berry DL. Oncology Nursing Society 2005–2009 Research Agenda. Pittsburgh: Oncology Nursing Society; 2007.
13. NCI. Report of the President’s Cancer Panel Living beyond cancer: Finding a new balance. Bethesda, MD: National Cancer Institute; 2004.
14. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. Feb 1996;14(2):671–679.
15. The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. Nov 1995;41(10):1403–1409.
16. Bloom JR, Kang SH, Petersen DM, Stewart SL. Quality of life in long-term cancer survivors. In: Feuerstein M, ed. Handbook of cancer survivorship. New York: Springer Publishing; 2007: 43–65
17. Buchanan DR, O’Mara AM, Kelaghan JW, Minasian LM. Quality-of-life assessment in the symptom management trials of the National Cancer Institute-supported Community Clinical Oncology Program. J Clin Oncol. Jan 20 2005;23(3):591–598.
18. Ferrans CE. Definitions and conceptual models of quality of life. In: Lipscomb J, Gotay, CC, Snyder, C, eds. Outcomes assessment in cancer: measures, methods, and applications. Cambridge: Cambridge University Press. 2005;14–30.
19. King CR, Ferrell BR, Grant M, Sakurai C. Nurses’ perceptions of the meaning of quality of life for bone marrow transplant survivors. Cancer Nurs. Apr 1995;18(2):118–129.
20. Haas BK. A multidisciplinary concept analysis of quality of life. West J Nurs Res. Dec 1999;21(6):728–742.
21. Ferrans CE. Development of a conceptual model of quality of life. Sch Inq Nurs Pract. Fall 1996;10(3):293–304.
22. Hacker ED. Quantitative measurement of quality of life in adult patients undergoing bone marrow transplant or peripheral blood stem cell transplant: A decade in review. Oncology Nursing Forum. 2003;30(4):613–629.
23. King CR. Advances in how clinical nurses can evaluate and improve quality of life for individuals with cancer. Oncology Nursing Forum. 2006;33(Suppl 1):5–12.
24. Moons P, Budts W, De Geest S. Critique on the conceptualization of quality of life: A review and evaluation of different conceptual approaches. Int J Nurs Stud. Sep 2006;43(7):891–901.
25. Anderson KL, Burckhardt CS. Conceptualization and measurement of quality of life as an outcome variable for health care intervention and research. J Adv Nurs. Feb 1999; 29(2):298–306.
26. Ferrans CE. Differences in what quality-of-life instruments measure. J Natl Cancer Inst Monogr. 2007(37):22–26.
27. Sousa KH, Williamson A. Symptom status and healthrelated quality of life: Clinical relevance. J Adv Nurs. Jun 2003;42(6):571–577.
28. Moinpour CM, Donaldson GW, Redman MW. Do general dimensions of quality of life add clinical value to symptom data? J Natl Cancer Inst Monogr. 2007;(37):31–38.
29. Lee S, Cook EF, Soiffer R, Antin JH. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2002;8(8):444–452.
30. Ware JE, Jr., Kosinski M, Bjorner JB, Turner-Bowker DM, Gandek B, Maruish ME. User’s manual for the SF-36v2 health survey. 2nd ed. Lincoln, RI: QualityMetric Incorporated; 2007.
31. Finlayson TL, Moyer CA, Sonnad SS. Assessing symptoms, disease severity, and quality of life in the clinical context: A theoretical framework. Am J Manag Care. May 2004; 10(5):336–344.
32. Lenz ER, Pugh LC. The theory of unpleasant symptoms. In: Smith MJ, Liehr PR, eds. Middle range theory for nursing. New York: Springer Publishing Company, Inc.; 2003:69–90.
33. Posey AD. Symptom perception: A concept exploration. Nurs Forum. Jul–Sep 2006;41(3):113–124.
34. Chang CH, Cella D, Clarke S, Heinemann AW, Von Roenn JH, Harvey R. Should symptoms be scaled for intensity, frequency, or both? Palliat Support Care. Mar 2003;1(1): 51–60.
35. Tishelman C, Degner LF, Rudman A, et al. Symptoms in patients with lung carcinoma: Distinguishing distress from intensity. Cancer. Nov 1 2005;104(9):2013–2021.
36. Wu AW, Dave NB, Diener-West M, Sorensen S, Huang IC, Revicki DA. Measuring validity of self-reported symptoms among people with HIV. AIDS Care. Oct 2004; 16(7):876–881.
37. Goodell TT, Nail LM. Operationalizing symptom distress in adults with cancer: A literature synthesis. Oncol Nurs Forum. Mar 2005;32(2):E42–47.
38. Lacasse C, Beck SL. Clinical Assessment of Symptom Clusters. Sem Oncol Nurs. 2007;23(2):106–112.
39. Cleeland C. Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. 2007;37:16–21.
40. Barsevick AM, Whitmer K, Nail LM, Beck SL, Dudley WN. Symptom cluster research: Conceptual, design, measurement, and analysis issues. J Pain Symptom Manage. Jan 2006;31(1): 85–95.
41. Beck SL. Symptom clusters: Impediments and suggestions for solutions. J Natl Cancer Inst Monogr. 2004(32):137–138.
42. Cella DF. Quality of life: Concepts and definition. J Pain Symptom Manage. Apr 1994;9(3):186–192.
43. Leidy NK. Functional status and the forward progress of merry- go-rounds: Toward a coherent analytical framework. Nurs Res. 1994;43(4):196–202.
44. Ferrans CE, Zerwic JJ, Wilbur JE, Larson JL. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37(4):336–342.
45. Belec RH. Quality of life: Perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum. Jan–Feb 1992;19(1):31–37.
46. Wilson IB, Cleary PD. Linking clinical variables with healthrelated quality of life. A conceptual model of patient outcomes. JAMA. Jan 4 1995;273(1):59–65.
47. Pearce NJ, Sanson-Fisher R, Campbell HS. Measuring quality of life in cancer survivors: A methodological review of existing scales. Psychooncology. Oct 31 2007.
48. Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. PharmacoEconomics. 2000;17(1):13–35.
49. Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. Nov-Dec 2007;10(Suppl 2):S94–S105.
50. Scientific Advisory Committee of the Medical Outcomes Trust. Assessing health status and quality of life instruments: Attributes and review criteria. Quality of Life Research, 2002; 11:193–205.
51. Rothman ML, Beltran P, Cappelleri JC, Lipscomb J, Teschendorf B. Patient-reported outcomes: Conceptual issues. Value Health. Nov-Dec 2007;10(Suppl 2):S66–75.
52. Lee SJ, Kim HT, Ho VT, et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplantation. Aug 2006;38(4):305–310.
53. Horwitz ME, Sullivan KM. Chronic graft-versus-host disease. Blood Reviews. Jan 2006;20(1):15–27.
54. Pavletic SZ, Smith LM, Bishop MR, et al. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stemcell transplantation. Am J Hematol. Apr 2005;78(4):265–274.
55. Remberger M, Kumlien G, Aschan J, et al. Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2002;8(12):674–682.
56. Lee SJ. New approaches for preventing and treating chronic graftversus- host disease. Blood. Jun 1 2005;105(11):4200–4206.
57. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.[see comment]. Journal of Clinical Oncology. Aug 15 2001;19(16):3685–3691.
58. Lee S. New approaches for preventing and treating chronic graftversus- host disease. Blood. Jun 1 2005;105(11):4200–4206.
59. Vogelsang GB, Lee L, Bensen-Kennedy DM. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annu Rev Med. 2003;54:29–52.
60. Duell T, van Lint MT, Ljungman P, et al. Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation. Ann Intern Med. Feb 1 1997;126(3):184–192.
61. Socie G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med. Jul 1 1999;341(1):14–21.
62. Singhal S, Mehta J. Reimmunization after blood or marrow stem cell transplantation. Bone Marrow Transplantation. 1999;23(7):637–646.
63. Lipscomb, J., Gottay, C. C., Snyder, C. (Eds) Outcomes assessment in cancer: Measures, methods, and applications. Cambridge University Press, 2004.
64. Bottomley A, Aaronson NK. International perspective on healthrelated quality-of-life research in cancer clinical trials: The European Organisation for Research and Treatment of Cancer experience. J Clin Oncol. Nov 10 2007;25(32):5082–5086.
65. Prieto JM, Atala J, Blanch J, et al. Psychometric study of quality of life instruments used during hospitalization for stem cell transplantation. J Psychosom Res. Aug 2004;57(2):201–211.
66. Tsimicalis A, Stinson J, Stevens B. Quality of life of children following bone marrow transplantation: Critical review of the research literature. Eur J Oncol Nurs. Sep 2005;9(3):218–238.
67. Mosher CE, Redd WH, Rini CM, Burkhalter JE, Duhamel KN. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: A review of the literature. Psychooncology. Aug 1 2008.
68. Baker F, Wingard JR, Curbow B, et al. Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant. May 1994;13(5):589–596.
69. Bush NE, Haberman M, Donaldson G, Sullivan KM. Quality of life of 125 adults surviving 6–18 years after bone marrow transplantation. Soc Sci Med. 1995;40(4):479–490.
70. Kiss TL, Abdolell M, Jamal N, Minden MD, Lipton JH, Messner HA. Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol. 2002;20(9):2334–2343.
71. Molassiotis A, Morris PJ. Quality of life in patients with chronic myeloid leukemia after unrelated donor bone marrow transplantation. Cancer Nurs. Oct 1999;22(5):340–349.
72. Socie G, Mary JY, Esperou H, et al. Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantation. Br J Haematol. 2001;113(1):194–201.
73. Syrjala KL, Chapko MK, Vitaliano PP, Cummings C, Sullivan KM. Recovery after allogeneic marrow transplantation: Prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplantation. 1993;11(4):319–327.
74. Worel N, Biener D, Kalhs P, et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplantation. 2002;30(9):619–626.
75. Molassiotis A. A correlational evaluation of tiredness and lack of energy in survivors of haematological malignancies. Eur J Cancer Care (Engl). Mar 1999;8(1):19–25.
76. Molassiotis A, Boughton BJ, Burgoyne T, van den Akker OB. Comparison of the overall quality of life in 50 long-term survivors of autologous and allogeneic bone marrow transplantation. J Adv Nurs. 1995;22(3):509–516.
77. Heinonen H, Volin L, Zevon MA, Uutela A, Barrick C, Ruutu T. Stress among allogeneic bone marrow transplantation patients. Patient Education and Counseling. 2005;56(1): 62–71.
78. Kopp M, Holzner B, Meraner V, et al. Quality of life in adult hematopoietic cell transplant patients at least 5 yr after treatment: A comparison with healthy controls. Eur J Haematol. Apr 2005;74(4):304–308.
79. Prieto JM, Saez R, Carreras E, et al. Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant. Jun 1996;17(6):1133–1142.
80. Andrykowski MA, Henslee PJ, Farrall MG. Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplantation. 1989;4(1): 75–81.
81. Andrykowski MA, Greiner CB, Altmaier EM, et al. Quality of life following bone marrow transplantation: Findings from a multicentre study. Br J Cancer. 1995;71(6):1322–1329.
82. Rusiewicz A, DuHamel KN, Burkhalter J, et al. Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psychooncology. Apr 2008;17(4):329–337.
83. Tierney DK, Facione N, Padilla G, Dodd M. Response shift: A theoretical exploration of quality of life following hematopoietic cell transplantation. Cancer Nurs. Mar-Apr 2007;30(2):125–138.
84. Osoba D. The clinical value and meaning of health-related quality-of-life outcomes in oncology. In: Lipscomb J, Gotay, CC, Snyder, C, eds. Outcomes assessment in cancer: measures, methods, and applications. Cambridge: Cambridge University Press; 2005:386–405.
85. Donaldson GW, Moinpour CM. Individual differences in quality- of-life treatment response. Med Care. Jun 2002;40(Suppl 6):III39–53.
86. Schwartz CE, Rapkin BD. Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal. Health Qual Life Outcomes. Mar 23 2004;2:16.
87. Visser MRM, Oort FJ, Sprangers MAG. Methods to detect response shift in quality of life data: A convergent validity study. Quality of Life Research. 2005;14(3):629–639.
88. Varricchio CG. Measurement issues in quality-of-life assessments. Oncol Nurs Forum. Jan 2006;33(Suppl 1):13–21.
89. Westerman MJ, Hak T, Sprangers MA, Groen HJ, van der Wal G, The AM. Listen to their answers! Response behaviour in the measurement of physical and role functioning. Qual Life Res. Apr 4 2008; 17(4):549–558.
90. Schwartz CE, Feinberg RG, Jilinskaia E, Applegate JC. An evaluation of a psychosocial intervention for survivors of childhood cancer: Paradoxical effects of response shift over time. Psychooncology. Jul-Aug 1999;8(4):344–354.
91. Feeny DH. The roles for preference-based measures in support of cancer research and policy. In: Lipscomb J, Gotay CC, Snyder C, eds. Outcomes assessment in cancer: Measures, methods and applications. New York: Cambridge University Press; 2005:69–92.
92. Grant J, Cranston A, Horsman J, et al. Health status and healthrelated quality of life in adolescent survivors of cancer in childhood. J Adolesc Health. May 2006;38(5):504–510.
93. Dobrez D, Cella D, Pickard AS, Lai JS, Nickolov A. Estimation of patient preference-based utility weights from the functional assessment of cancer therapy – general. Value Health. Jul-Aug 2007;10(4):266–272.
94. Furlong W, Barr RD. Commentary on Cox CL, Lensing S, Rai SN et al. Proxy assessment of quality of life in pediatric clinical trials: Application of the Health Utilities Index 3. Qual Life Res 2005; 14: 1045–1056. Qual Life Res. Sep 2006;15(7):1291–1293; discussion 1295–1296.
95. Bjorner JB, Wallenstein GV, Martin MC, et al. Interpreting score differences in the SF-36 Vitality scale: Using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin. Apr 2007;23(4):731–739.
96. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care. May 2003;41(5): 582–592.
97. Jones JB, Snyder CF, Wu AW. Issues in the design of Internetbased systems for collecting patient-reported outcomes. Qual Life Res. Oct 2007;16(8):1407–1417.
98. Carpenter JS, Rawl S, Porter J, et al. Oncology outpatient and provider responses to a computerized symptom assessment system. Oncol Nurs Forum. Jul 2008;35(4):661–669.
99. Bush N, Donaldson G, Moinpour C, et al. Development, feasibility and compliance of a web-based system for very frequent QOL and symptom home self-assessment after hematopoietic stem cell transplantation. Qual Life Res. Feb2005;14(1):77–93.
100. Garcia SF, Cella D, Clauser SB, et al. Standardizing patientreported outcomes assessment in cancer clinical trials: A patient-reported outcomes measurement information system initiative. J Clin Oncol. Nov 10 2007;25(32):5106–5112.
101. Cella D, Yount S, Rothrock N, et al. PROMIS Cooperative Group. Med Care. 2007 May;45(5 Suppl 1):S3–S11.
102. Rose M, Bjorner JB, Becker J, Fries JF, Ware JE. Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported OutcomesMeasurement Information System (PROMIS). J Clin Epidemiol. Jan 2008;61(1):17–33.
103. McHorney CA, Cook KF. The ten Ds of health outcomes measurement for the twenty-first century. In: Lipscomb J, Gotay, CC, Snyder, C, eds. Outcomes Assessment in Cancer: Measures, methods, and applications. Cambridge: Cambridge University Press; 2005:590–609.
104. McHorney CA. Generic health measurement: Past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med. Oct 15 1997;127(8 Pt 2):743–750.
105. Butt Z, Wagner LI, Beaumont JL, et al. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage. Jan 2008;35(1):20–30.
106. Martin P. Seattle Symposium on Cancer Research Outcomes: Commentary on the papers by Donaldson and Moinpour and by Osoba. Med Care. Jun 2002;40(Suppl 6):III54–55.
107. Lipscomb, J., Donaldson, M. S. Hiatt, R. A. (2007). Cancer outcomes research and the arenas of application. JNCI Monographs, 33, 1–7